- Home
- Life Sciences
- Pharmaceutical
- Generic Drug
- Generic Drug Analysis & Statistics, May 2013 (p2)
Talk to Alison
(866) 682 9815
Search inside this page
Top countries
- United States (71)
- Germany (27)
- India (58)
- Philippines (10)
- Singapore (8)
-
- South Korea (14)
- Czech Republic (37)
- France (20)
- Netherlands (15)
- Poland (37)
- Romania (40)
- Russian Federation (116)
- Slovakia (slovak Republic) (30)
- Spain (16)
- Switzerland (10)
- World (69)
- Europe (58)
- Egypt (31)
- South Africa (33)
- Israel (32)
Publication dates
Publishers
- GenericsWeb - Selector 7 (394)
- Generics Web - Selector 44 (394)
- GenericsWeb (348)
- Global Data (23)
- Business Monitor International (1 211)
-
- Firstword Pharma (6)
- Ibisworld (2)
- MarketLine (26)
- Chinascope Financial (2)
- Urch Publishing (73)
- Espicom Business Intelligence (42)
- Datamonitor (34)
- RNCOS (16)
- Frost & Sullivan (11)
- GBI Research (10)
- Global Markets Direct (10)
- Life Science Analytics (LSA) (8)
- Visiongain (8)
- BCC Research (5)
- SeeNews - Research & Profiles (5)
- Euromonitor International (4)
- SCRIP Insights (4)
- Global Industry Analyst (3)
- Arrowhead (2)
- Aruvian's R'search (2)
- ICD Research (2)
- Arena (1)
- Business Review (1)
- CCM International Limited (1)
- CHI Insight Pharma Reports (1)
- Cygnus Business Consulting and Research (1)
- Emerging Markets Direct Media Holdings (1)
- Huidian Research (1)
- Industry Experts (1)
- Infiniti Research Limited (1)
- Koncept Analytics (1)
- Kuick Research (1)
- Mintel (1)
- Plimsoll Publishing Ltd UK (1)
- Red Mountain Insights (1)
- Smart Research Insights (1)
- Venture Planning Group (1)
All regions
-
- Bahrain (6)
- Bangladesh (6)
- China (21)
- India (58)
- Indonesia (10)
- Iraq (1)
- Israel (32)
- Japan (54)
- Jordan (6)
- Kazakhstan (31)
- Kuwait (6)
- Lebanon (31)
- Malaysia (10)
- North Korea (1)
- Oman (30)
- Pakistan (6)
- Philippines (10)
- Qatar (6)
- Saudi Arabia (8)
- Singapore (8)
- South Korea (14)
- Syrian Arab Republic (1)
- Taiwan (6)
- Thailand (8)
- Turkey (2)
- United Arab Emirates (6)
- Uzbekistan (6)
- Vietnam (8)
-
- Albania (1)
- Austria (2)
- Belarus (6)
- Belgium (11)
- Bulgaria (34)
- Croatia (31)
- Czech Republic (37)
- Estonia (26)
- Finland (6)
- France (20)
- Germany (27)
- Greece (26)
- Hungary (33)
- Iceland (1)
- Ireland (2)
- Italy (16)
- Latvia (32)
- Lithuania (7)
- Moldova, Republic Of (31)
- Netherlands (15)
- Norway (2)
- Poland (37)
- Portugal (11)
- Romania (40)
- Russian Federation (116)
- Serbia and Montenegro (32)
- Slovakia (slovak Republic) (30)
- Slovenia (27)
- Spain (16)
- Sweden (7)
- Switzerland (10)
- Ukraine (32)
- United Kingdom (24)
-
- Australia (18)
- Austria (2)
- Belgium (11)
- Canada (45)
- Chile (32)
- Czech Republic (37)
- Estonia (26)
- Finland (6)
- France (20)
- Germany (27)
- Greece (26)
- Hungary (33)
- Iceland (1)
- Ireland (2)
- Israel (32)
- Italy (16)
- Japan (54)
- Mexico (39)
- Netherlands (15)
- New Zealand (10)
- Norway (2)
- Poland (37)
- Portugal (11)
- Slovenia (27)
- South Korea (14)
- Spain (16)
- Sweden (7)
- Switzerland (10)
- Turkey (2)
- United Kingdom (24)
- United States (71)
data types
Free Market Research Guides to Download
Generic Drug Analysis & Statistics, May 2013 (p2)
» Purchase Premium Reports
31-70 of about 1 500 reports
Etoricoxib - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Paclitaxel - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Saquinavir - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Treprostinil - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Telmisartan - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Cefixime - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Temsirolimus - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Telavancin - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Fidaxomicin - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Cefpodoxime - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Tenofovir - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Posaconazole - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Cefdinir - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Etravirine - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Oseltamivir - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Candesartan - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Moxifloxacin - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Sitagliptin - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Emtricitabine - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Ertapenem - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Flomoxef - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Liraglutide - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Fingolimod - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Asenapine - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Ceftaroline Fosamil - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Atazanavir - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Sorafenib - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Azilsartan - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Olmesartan - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Eprosartan - Comprehensive patent search
- $ 7 200
- Company report
- May 2013
- by GenericsWeb
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...
- Industries : Generic Drug
Belarus Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2022
By Business Monitor International
Source: "Association of International Pharmaceutical Manufacturers in Russia and Research Marketing &
- Industries : Generic Drug
- Countries : Belarus, Russian Federation
Czech Republic Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: State Institute for Drug Control (SUKL), Association of the European Self-Medication Industry (AESGP
- Industries : Generic Drug
- Countries : Czech Republic
China Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: Southern Medicine Economic Institute (SMEI), Association of the European Self-Medication Society (AE
- Industries : Generic Drug
- Countries : China
Bahrain Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2009 To 2021
By Business Monitor International
Source: BMI
- Industries : Generic Drug
- Countries : Bahrain
Egypt Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2021
By Business Monitor International
Source: Ministry Of Health, local news sources, domestic companies, BMI
- Industries : Generic Drug
- Countries : Egypt
Number Of Approvals Of Registration-drug_clinical Trials Of Generic Drug-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Generic Drug
Number Of Approvals Of Registration-drug_generic Drug Production-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Generic Drug
Belgium Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2021
By Business Monitor International
Source: Ministry of Health, National Bureau of Statistics, Association of the European Self-Medication Indus
- Industries : Generic Drug
- Countries : Belgium
Australia Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: IMS Health, Organisation for Economic Co-operation and Development (OECD), BMI
- Industries : Generic Drug
- Countries : Australia
United Arab Emirates Generic Drug Sales, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2021
By Business Monitor International
Source: BMI
- Industries : Generic Drug
- Countries : United Arab Emirates
» Download Public Reports
About 500 reports
Company Report: Generic Drug in India for Year 2013
- Company report
- March 2013
- 3 pages
Generic Drug Industry Overview
March 2013» Read our Company Profiles
9 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandSanofi-Aventis Senegal
SenegalJohnson and Johnson
United StatesMylan Inc.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
